Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16730592 | 0.91 | — | — | |
| SCHEMBL12807355 | 0.85 | ALDH1A1 (0.38) | — | |
| SCHEMBL2051876 | 0.84 | — | — | |
| SCHEMBL17729826 | 0.84 | — | — | |
| SCHEMBL9813280 | 0.82 | CA1 (0.33) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL28963148 | 0.81 | CA1 (0.36) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL15827706 | 0.81 | CYP1A2 (0.37) | — | |
| SCHEMBL497018 | 0.78 | CA1 (0.34) | CA1CA2CA12CA9 | |
| SCHEMBL22652995 | 0.78 | CA1 (0.31) | CA1CA2CA12CA9 | |
| SCHEMBL5069451 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025066075-A1 | ELECTROLYTE AND ALKALI METAL SECONDARY BATTERY CONTAINING SAME | 中国科学院苏州纳米技术与纳米仿生研究所 | 2025-04-03 | — | — | WO | claimed |
| CN-119695283-A | Electrolyte and alkali metal secondary battery containing same | 中国科学院苏州纳米技术与纳米仿生研究所 | 2025-03-25 | — | — | CN | claimed |
| CN-117013085-A | Weak solvation electrolyte and lithium-sulfur battery and lithium ion battery containing same | 中国科学院苏州纳米技术与纳米仿生研究所 | 2023-11-07 | — | — | CN | claimed |
| WO-2025066075-A1 | ELECTROLYTE AND ALKALI METAL SECONDARY BATTERY CONTAINING SAME | 中国科学院苏州纳米技术与纳米仿生研究所 | 2025-04-03 | — | — | WO | disclosed |
| CN-119695283-A | Electrolyte and alkali metal secondary battery containing same | 中国科学院苏州纳米技术与纳米仿生研究所 | 2025-03-25 | — | — | CN | disclosed |
| CN-111630031-B | Process for producing quinolin-4 (1H) -one derivative | 日本化药株式会社 | 2024-03-12 | — | — | CN | disclosed |
| WO-2023220541-A1 | TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES COMPOUNDS AS HPK1 INHIBITORS | MERCK PATENT GMBH (DE) | 2023-11-16 | — | — | WO | disclosed |
| CN-117013085-A | Weak solvation electrolyte and lithium-sulfur battery and lithium ion battery containing same | 中国科学院苏州纳米技术与纳米仿生研究所 | 2023-11-07 | — | — | CN | disclosed |
| US-20230312605-A1 | PYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF | TENARX, INC. | 2023-10-05 | — | — | US | disclosed |
| US-11760701-B2 | Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YROK (US) | 2023-09-19 | — | — | US | disclosed |
| US-11760701-B2 | Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YROK (US) | 2023-09-19 | — | — | US | disclosed |
| US-20120041028-A1 | BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE | GLAXO GROUP LIMITED | 2012-02-16 | — | — | US | disclosed |
| EP-2116522-A1 | PENTACYCLIC LIQUID CRYSTAL COMPOUND HAVING CF<SB>2</SB>O BONDING GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | Chisso Corporation (JP) | 2009-11-11 | — | — | EP | disclosed |
| EP-1607463-B1 | LIQUID CRYSTAL COMPOSITION | DAINIPPON INK & CHEMICALS (JP) | 2008-09-24 | — | — | EP | disclosed |
| US-7405026-B2 | Liquid crystal composition | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2008-07-29 | — | — | US | disclosed |
| US-20060172089-A1 | Liquid crystal composition | DAINIPPON INK AND CHEMICALS, INC., (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1607463-A1 | LIQUID CRYSTAL COMPOSITION | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-12-21 | — | — | EP | disclosed |
| JP-2004256442-A | METHOD FOR PRODUCING TRIFLUOROMETHOXYCYCLOHEXANES | DAINIPPON INK & CHEM INC | 2004-09-16 | — | — | JP | disclosed |
| US-4149016-A | Perfluoroethers | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1979-04-10 | — | — | US | disclosed |
| US-4077857-A | Method for the preparation of perfluoroethers | THE UNITES STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041028-A1 | BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE | CHRM1, CHRM2, CHRM4 | CA1 1096/4885CA2 2331/4885CA12 3845/4885 |
| US-20230312605-A1 | PYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF | DYRK1A, DYRK2, DYRK1B | CA1 3216/4885CA2 3671/4885CA12 3857/4885 |
| US-11760701-B2 | Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same | AFF2, AFF4, AFF1 | CA1 3362/4885CA2 4213/4885CA12 3160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.